583 related articles for article (PubMed ID: 30420297)
1. Natural Variations in BRLF1 Promoter Contribute to the Elevated Reactivation Level of Epstein-Barr Virus in Endemic Areas of Nasopharyngeal Carcinoma.
Zhang JB; Huang SY; Wang TM; Dong SQ; He YQ; Zheng XH; Li XZ; Wang F; Jianbing M; Jia WH
EBioMedicine; 2018 Nov; 37():101-109. PubMed ID: 30420297
[TBL] [Abstract][Full Text] [Related]
2. Expression of Epstein-Barr virus lytic gene BRLF1 in nasopharyngeal carcinoma: potential use in diagnosis.
Feng P; Ren EC; Liu D; Chan SH; Hu H
J Gen Virol; 2000 Oct; 81(Pt 10):2417-2423. PubMed ID: 10993929
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr Virus BRLF1 Induces PD-L1 Expression in Nasopharyngeal Carcinoma Cells.
Wu CC; Chen MS; Lee TY; Huang TS; Cho DY; Chen JY
Viral Immunol; 2024 Mar; 37(2):115-123. PubMed ID: 38498796
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Epstein-Barr virus reactivation in nasopharyngeal carcinoma cells by dietary sulforaphane.
Wu CC; Chuang HY; Lin CY; Chen YJ; Tsai WH; Fang CY; Huang SY; Chuang FY; Lin SF; Chang Y; Chen JY
Mol Carcinog; 2013 Dec; 52(12):946-58. PubMed ID: 22641235
[TBL] [Abstract][Full Text] [Related]
5. A single nucleotide polymorphism in the Epstein-Barr virus genome is strongly associated with a high risk of nasopharyngeal carcinoma.
Feng FT; Cui Q; Liu WS; Guo YM; Feng QS; Chen LZ; Xu M; Luo B; Li DJ; Hu LF; Middeldorp JM; Ramayanti O; Tao Q; Cao SM; Jia WH; Bei JX; Zeng YX
Chin J Cancer; 2015 Dec; 34(12):563-72. PubMed ID: 26675171
[TBL] [Abstract][Full Text] [Related]
6. Genome sequencing analysis identifies Epstein-Barr virus subtypes associated with high risk of nasopharyngeal carcinoma.
Xu M; Yao Y; Chen H; Zhang S; Cao SM; Zhang Z; Luo B; Liu Z; Li Z; Xiang T; He G; Feng QS; Chen LZ; Guo X; Jia WH; Chen MY; Zhang X; Xie SH; Peng R; Chang ET; Pedergnana V; Feng L; Bei JX; Xu RH; Zeng MS; Ye W; Adami HO; Lin X; Zhai W; Zeng YX; Liu J
Nat Genet; 2019 Jul; 51(7):1131-1136. PubMed ID: 31209392
[TBL] [Abstract][Full Text] [Related]
7. Genetic variants in NKG2D axis and susceptibility to Epstein-Barr virus-induced nasopharyngeal carcinoma.
Viet NH; Trung NQ; Dong LT; Trung LQ; Espinoza JL
J Cancer Res Clin Oncol; 2021 Mar; 147(3):713-723. PubMed ID: 33392659
[TBL] [Abstract][Full Text] [Related]
8. Detection of methylation status of Epstein-Barr virus DNA C promoter in the diagnosis of nasopharyngeal carcinoma.
Zheng XH; Wang RZ; Li XZ; Zhou T; Zhang JB; Zhang PF; Lu LX; Jia WH
Cancer Sci; 2020 Feb; 111(2):592-600. PubMed ID: 31834989
[TBL] [Abstract][Full Text] [Related]
9. An epidemiological and molecular study of the relationship between smoking, risk of nasopharyngeal carcinoma, and Epstein-Barr virus activation.
Xu FH; Xiong D; Xu YF; Cao SM; Xue WQ; Qin HD; Liu WS; Cao JY; Zhang Y; Feng QS; Chen LZ; Li MZ; Liu ZW; Liu Q; Hong MH; Shugart YY; Zeng YX; Zeng MS; Jia WH
J Natl Cancer Inst; 2012 Sep; 104(18):1396-410. PubMed ID: 22972969
[TBL] [Abstract][Full Text] [Related]
10. Methylation profiling of Epstein-Barr virus immediate-early gene promoters, BZLF1 and BRLF1 in tumors of epithelial, NK- and B-cell origins.
Li L; Su X; Choi GC; Cao Y; Ambinder RF; Tao Q
BMC Cancer; 2012 Mar; 12():125. PubMed ID: 22458933
[TBL] [Abstract][Full Text] [Related]
11. EBV reactivation as a target of luteolin to repress NPC tumorigenesis.
Wu CC; Fang CY; Hsu HY; Chuang HY; Cheng YJ; Chen YJ; Chou SP; Huang SY; Lin SF; Chang Y; Tsai CH; Chen JY
Oncotarget; 2016 Apr; 7(14):18999-9017. PubMed ID: 26967558
[TBL] [Abstract][Full Text] [Related]
12. Identification of genomic alterations in nasopharyngeal carcinoma and nasopharyngeal carcinoma-derived Epstein-Barr virus by whole-genome sequencing.
Tu C; Zeng Z; Qi P; Li X; Guo C; Xiong F; Xiang B; Zhou M; Liao Q; Yu J; Li Y; Li X; Li G; Xiong W
Carcinogenesis; 2018 Dec; 39(12):1517-1528. PubMed ID: 30102338
[TBL] [Abstract][Full Text] [Related]
13. Sequence analysis of the Epstein-Barr virus (EBV) BRLF1 gene in nasopharyngeal and gastric carcinomas.
Jia Y; Wang Y; Chao Y; Jing Y; Sun Z; Luo B
Virol J; 2010 Nov; 7():341. PubMed ID: 21106109
[TBL] [Abstract][Full Text] [Related]
14. 5-hydroxymethylation of the EBV genome regulates the latent to lytic switch.
Wille CK; Nawandar DM; Henning AN; Ma S; Oetting KM; Lee D; Lambert P; Johannsen EC; Kenney SC
Proc Natl Acad Sci U S A; 2015 Dec; 112(52):E7257-65. PubMed ID: 26663912
[TBL] [Abstract][Full Text] [Related]
15. Multiplex Epstein-Barr virus BALF2 genotyping detects high-risk variants in plasma for population screening of nasopharyngeal carcinoma.
Miller JA; Sahoo MK; Yamamoto F; Huang C; Wang H; Zehnder JL; Le QT; Pinsky BA
Mol Cancer; 2022 Jul; 21(1):154. PubMed ID: 35902864
[TBL] [Abstract][Full Text] [Related]
16. Use of adenovirus vectors expressing Epstein-Barr virus (EBV) immediate-early protein BZLF1 or BRLF1 to treat EBV-positive tumors.
Feng WH; Westphal E; Mauser A; Raab-Traub N; Gulley ML; Busson P; Kenney SC
J Virol; 2002 Nov; 76(21):10951-9. PubMed ID: 12368338
[TBL] [Abstract][Full Text] [Related]
17. EBV genome variations enhance clinicopathological features of nasopharyngeal carcinoma in a non-endemic region.
Kondo S; Okuno Y; Murata T; Dochi H; Wakisaka N; Mizokami H; Moriyama-Kita M; Kobayashi E; Kano M; Komori T; Hirai N; Ueno T; Nakanishi Y; Endo K; Sugimoto H; Kimura H; Yoshizaki T
Cancer Sci; 2022 Jul; 113(7):2446-2456. PubMed ID: 35485636
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of nasopharyngeal carcinoma growth by RTA-expressing baculovirus vectors containing oriP.
Wang L; Shan L; Lo KW; Yin J; Zhang Y; Sun R; Zhong J
J Gene Med; 2008 Oct; 10(10):1124-33. PubMed ID: 18642396
[TBL] [Abstract][Full Text] [Related]
19. Determination and genome-wide analysis of Epstein-Barr virus (EBV) sequences in EBV-associated gastric carcinoma from Guangdong, an endemic area of nasopharyngeal carcinoma.
Chen JN; Zhou L; Qiu XM; Yang RH; Liang J; Pan YH; Li HF; Peng GR; Shao CK
J Med Microbiol; 2018 Nov; 67(11):1614-1627. PubMed ID: 30239329
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus mRNA profiles and viral DNA methylation status in nasopharyngeal brushings from nasopharyngeal carcinoma patients reflect tumor origin.
Ramayanti O; Juwana H; Verkuijlen SA; Adham M; Pegtel MD; Greijer AE; Middeldorp JM
Int J Cancer; 2017 Jan; 140(1):149-162. PubMed ID: 27600027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
